论文部分内容阅读
Boehringer Ingelheim公司开发的治疗慢性阻塞性肺病的抗胆碱能新药tiotropium计划于2002年初上市。这是第一个每日吸入1次长效支气管扩张药。
The tiotropium, an anticholinergic drug developed by Boehringer Ingelheim for the treatment of chronic obstructive pulmonary disease, is scheduled to be available in early 2002. This is the first daily inhalation of long-acting bronchodilators.